A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors

Jayesh Desai, Ben Markman, Shahneen Kaur Sandhu, Hui Kong Gan, Michael Friedlander, Ben Tran, Tarek Meniawy, Vishal Boolell, Duncan Colyer, Christie Norris, Malaka Ameratunga, Jason Yang, Kang Li, Lai Wang, Lusong Luo, Zhen Qin, Michael Millward

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Volume34
Issue number15
DOIs
Publication statusPublished - 20 May 2016
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States
Duration: 3 Jun 20167 Jun 2016

Cite this